The Gimap gene family has been shown to be integral to T cell survival and development. A frameshift mutation in Gimap5, one of seven members of the Gimap family, results in lymphopenia and is a prerequisite for spontaneous type 1 diabetes (T1D) in the BioBreeding (BB) rat. While not contributing to lymphopenia, the Gimap family members proximal to Gimap5, encompassed within the Iddm39 quantitative trait locus (QTL), have been implicated in T1D. We hypothesized that expression of the Gimap family members within the Iddm39 QTL, during thymocyte development as well as in peripheral T and B cell subsets, may contribute to T1D. Quantitative real time (qRT) PCR analysis of cell sorted subpopulations showed that expression of Gimap4 was reduced in DR. lyp/lyp rat double negative, double positive and CD8 single positive (SP) thymocytes while expression of Gimap8, Gimap6, and Gimap7 was reduced only in CD8 SP thymocytes. Interestingly, expression of the entire Gimap gene family was reduced in DR. lyp/lyp rat peripheral T cells compared to non-lymphopenic, non-diabetic DR. +/+ rats.
INTRODUCTION
The GTPase immunity-associated protein (Gimap) gene family in the rat is comprised of eight genes located within 150 Kb on rat chromosome (RNO) 4 [1, 2] . The seven functional Gimap genes in rat; Gimap8, Gimap9, Gimap4, Gimap6, Gimap7, Gimap1 and Gimap5 are conserved across multiple vertebrates including human and mouse as well as in Arabidopsis thaliana [2] [3] [4] . These small GTPases regulate pro-and anti-apoptotic T cell pathways [5] [6] [7] [8] [9] [10] [11] [12] as well as thymocyte maturation and differentiation [7, 13] and are characterized by novel guanosine diphosphate/guanosine triphosphate (AIG1) and coiledcoil domains, common binding motifs and variable C termini [2, 4] .
Peripheral T cell lymphopenia in the BioBreeding (BB) diabetes prone (DP) rat is linked to a single nucleotide deletion in Gimap5 (Iddm2; lyp) resulting in a premature stop codon and truncation of the full-length protein [4, 14] . This truncation results in loss of Gimap5 protein expression [16] and is a prerequisite for onset of spontaneous type 1 diabetes (T1D) in the DP rat [4, 15] . Normal Gimap5 transcript and protein levels were restored in the F344. lyp/lyp rat containing a 150-kb P1 artificial chromosome (PAC) transgene harboring the wild-type Gimap5 allele [16] . While the Gimap5 mutation was not associated with T1D in humans [17] , the uncommon SNP in the polyadenylation signal of human GIMAP5 was found to be associated with risk for high IA-2 autoantibody levels in T1D patients [18] implicating a possible role in islet autoimmunity. The common SNP at this location was associated with systemic lupus erythematosus underscoring the possible contribution of GIMAP5 to autoimmunity [19] .
Positional cloning of Gimap5 was in part due to generation of the DR.lyp congenic rat line with 2 Mb of DP DNA, encompassing Gimap5, introgressed onto the BB diabetes resistant (DR) genetic background [4, 15, 20] . DR. lyp/lyp rats, homozygous for the DP DNA introgression, are 100% lymphopenic and 100% develop diabetes by 84 days of age [15] . In contrast, 34 Mb of F344 DNA, introgressed proximal to Gimap5 in the DR. lyp/lyp rat, generates rats that are 100% lymphopenic but protected from T1D development (DRF. f/f ) [15, 21] . Development of DRF. f/f congenic sublines revealed two quantitative trait loci (QTL) encompassed within the 34 Mb F344 DNA interval on RNO4, each of which confer partial protection from spontaneous T1D in the DR. lyp/lyp rat [21] . The first, Iddm38 (previously referred to as Region 1), is a 670 Kb interval encompassing the TCR Vβ and Trypsin gene sequences. The second, Iddm39 (previously referred to as Region 2) maps to within the 340 Kb proximal to Gimap1 and Gimap5. Thus, it cannot be excluded that the Gimap genes proximal to Gimap1; Gimap8, Gimap9, Gimap4, Gimap6 and Gimap7 play a role in onset of T1D in the DR. lyp/lyp rat.
Gimap8, Gimap9, Gimap4, and Gimap7 are transcribed in the same direction while Gimap6 runs opposite to the rest of the family. Each gene is separated by approximately 12 Kb of non-coding sequence. Gimap8, unique with three AIG1 binding domains [1, 2, 7, 22] , localizes to the endoplasmic reticulum, Golgi and mitochondria and may play an anti-apoptotic role in immune cells [8] . Gimap6 and Gimap7 are transmembrane proteins containing weak endoplasmic reticulum (ER) localization signals [2] . Gimap4, a cytosolic lymphoid specific signaling molecule, is associated with β-selection during maturation of CD4-CD8-double negative (DN) thymocytes into CD4+CD8+ double positive (DP) thymocytes [5, 23] , positive selection of T cells and accelerated T cell apoptosis [5, 7, 24] . In activated CD4+ cord blood cells, expression of Gimap4 is downregulated in response to IL-4, a Th2 promoting cytokine, and up-regulated by IL-12, a stimulator of IFN-γ production and promoter of Th1 differentiation [25] .
Our previous study of the Gimap family showed that all seven members are differentially expressed in DR. +/+ and DR. lyp/lyp spleen, thymus and mesenteric lymph node (MLN) [1] .
However, as whole organs, not pure populations of cells were studied, it remains uncertain to what extent the observed differences were due to the cellular composition of these organs which are markedly affected by the reduction of T cells and a concordant increase in B cells and monocytes. To investigate these Gimap gene expression variations in sorted subpopulations of cells, we performed quantitative real time (qRT) PCR analysis on purified T and B cells from DR. +/+ and DR. lyp/lyp rat thymus, spleen and MLN.
We chose to study lymphocytes from MLN in the BB rats because their defective intestinal permeability may permit passage of intestinal environmental antigens initiating an autoimmune response, triggering diabetes and changes in expression of Gimap genes.
While not contributing to lymphopenia, we tested the hypothesis that a Gimap family member, other than Gimap5 and Gimap1, is associated with T1D to explain the iddm39 QTL. Clarifying Gimap gene expression in specific tissue-cells populations will aid in our understanding of the role of the Gimap family not only in thymocyte development, T cell survival in the periphery, or both, but also in T1D.
MATERIALS AND METHODS
DR.lyp Rats.
The DR.lyp (BBDR.BBDP-(D4Rhw17-SS99306861)(D4Rhw11-D4Rhw10)/Rhw) congenic rat line was derived from animals with two independent recombination events developed from our previously described introgression of the lymphopenia locus by cyclic cross-intercross breeding of BBDP with BBDR rats [26] . The first recombination event was flanked by simple sequence length polymorphism (SSLP) marker D4Rhw11 Between 25 and 30 days of age, 2 mm tail snips were obtained and DNA isolated as previously described [21] . The isolated DNA samples were diluted to 25 ng/µL in regions of the transcripts where there is more variation between the different Gimap genes and subjected to BLAST alignment to ensure specificity. The primers and probes used for each gene are detailed elsewhere [1] . Primers were obtained from Integrated DNA Technologies (Coralville, IA) or Qiagen Operon (Valencia, CA). Fluorescently labeled probes were obtained from Integrated DNA Technologies. Representative qRT-PCR products for each gene were run on an agarose gel to check for primer pair binding specificity. These PCR amplicons (used to convert to copy number) were quantitated in triplicate wells with the PicoGreen® RNA Quantitation Kit (Molecular Probes, Eugene, OR) using standards supplied by the manufacturer. Results from each assay were validated and normalized against GAPDH. The standard curves showed the following reaction efficiencies; Gimap8: 96% ± 3 SD, Gimap9: 94% ± 1 SD, Gimap4: 92% ± 2 Page 10 of 23 SD, Gimap6: 90% ± 3 SD, Gimap7: 91% ± 4 SD, Gimap1: 94% ± 2 SD, Gimap5: 92% ± 2 SD, Lr8: 94% ± 3 SD, and GAPDH: 92% ± 1 SD.
Statistics.
Analyses of Gimap gene expression were carried out using linear mixed effect models [27] with SPLUS (Insightful Corp., Seattle, WA). Comparisons of expression between cell types consisted of twelve rats with two repeated measures for each rat. Comparison between DR. lyp/lyp and DR. +/+ genotypes consisted of six rats from three litters consisting of one DR. lyp/lyp and one DR. +/+ rat in each litter and two repeated measures for each rat.
All of these analyses contained random effects for each of the three litters and two measures for each rat nested within those litters. Likelihood ratio tests were used to test the need for random intercepts. The significance for the fixed effects were assessed by F test for the coefficient or the group of coefficients [28] A Bonferroni correction was applied to p-values to adjust for multiple comparisons and adjusted values were considered significant at p < 0.05. As in the thymus, spleen and MLN, Gimap1 did not express appreciably in either DR. +/+ or DR. lyp/lyp rat B or non B cells (Figure V) .
RESULTS
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DISCUSSION
The Gimap5 mutation within the lyp critical interval has been documented to result in peripheral T cell lymphopenia in the DR. lyp/lyp rat [4, 14, 22] . In our previous qRT-PCR analysis we showed reduced expression of all seven Gimap genes; Gimap8, Gimap9, Gimap4, Gimap6, Gimap7, Gimap1 and Gimap5 in DR. lyp/lyp rat spleen and MLN when compared to DR. +/+ while only four; Gimap9, Gimap4, Gimap1, and Gimap5 were reduced in thymus [1] . The present study resolves these previously observed expression differences to specific cell types both during thymocyte development and to mature T cells in the periphery. As lymphopenia impacts the cellular composition of the spleen and MLN, but not necessarily the thymus, the present qRT-PCR analysis of sorted cells further substantiates the Gimap5 frameshift mutation as the primary defect in the periphery.
Three of the Gimap genes within the Iddm39 QTL; Gimap8, Gimap6 and Gimap7 as well as the Gimap5 gene itself were expressed in DN and DP thymocytes with no significant difference in expression between DR. +/+ and DR. lyp/lyp rats. Interestingly, while these genes were turned on during maturation of DN to DP thymocytes, no impact of the Gimap5 mutation on gene expression was observed, as was seen in the periphery. Upon transition from DP to SP thymocytes, expression of four of the Iddm39 genes; Gimap8, Gimap4, Gimap6 and Gimap7 as well as Gimap5 increased in CD4 SP thymocytes and showed the highest overall expression as compared to the other three stages of thymocyte development however only Gimap4 and Gimap5 showed expression variation between DR. +/+ and DR. lyp/lyp rats. These same five Gimap genes were poorly expressed in CD8 SP thymocytes and all showed a significant difference in expression between DR. +/+ and DR. lyp/lyp rats. We believe this apparent reduction in expression of Gimap8, Gimap4, Gimap6, Gimap7 and Gimap5 in DR. lyp/lyp CD8+ cells before leaving the thymus is a significant observation that may aid in understanding the possible role of the Gimap genes in T cells as well as their possible role in the pathogenesis of T1D.
The possible role of the Gimap genes in either protection from T cell apoptosis, such as Gimap5 [6, 7, 12] and Gimap8 [8] , or to induce apoptosis such as Gimap4 [7] would perhaps explain the severe lack of CD8+ T cells in peripheral blood and tissues. Gimap4
and Gimap5 interact with the Bcl-2 family of signal transduction molecules to regulate the mitochondrial mediated T cell apoptosis pathway [7] . The lower observed expression of Gimap4 in the DR. lyp/lyp CD4+ SP thymocytes would potentially explain that more CD4+ and less CD8+ T cells are detected in peripheral blood and tissues. It is however not understood why CD8+ cells are expressing less of all the Gimap genes, whether from DR. +/+ or DR. lyp/lyp rats, or how this low expression impacts the ability of CD8+ T cells to survive in the periphery.
The major finding from the analysis of CD3+ spleen and MLN T cells sorted for either CD4 or CD8 positivity was that all the Gimap genes, except Gimap9 and Gimap1, whether in the Iddm39 QTL or the lyp critical interval showed reduced expression in the cells from the DR. lyp/lyp rats. While the Gimap genes showed the highest expression levels overall in cells sorted from the spleen and MLN, the difference in Gimap gene expression between DR. +/+ and DR. lyp/lyp appeared more pronounced than in CD4 or CD8 SP thymocytes. The study of lymphocytes from MLN is justified because it is well known that the defective intestinal permeability associated with BB rats may permit passage of environmental antigens initiating an autoimmune response and triggering T1D (1.
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It should be noted that the same number of cells were sorted from both the spleen and the The nature of the Gimap5 frame shift mutation leading to the absence of the Gimap5 protein [4, 16] suggests that the loss of this anti-apoptotic protein contributes to lymphopenia. The importance of the Gimap5 mutation for the DR. lyp/lyp rat lymphopenia was amply illustrated by the marked reduction in expression of the Gimap5 in the non B cells sorted from the spleen or the MLN. As the Gimap5 mutation is comparable to a null mutation, i.e. no Gimap5 protein is made [4, 16] it is of interest to note that the Gimap5 knock out mouse that we recently reported [29] resulted in impaired thymocyte maturation as well as survival of peripheral CD4 and CD8 positive T cells. Gimap5 deficiency also blocked natural killer and NKT cell differentiation which could be restored on transfer of Gimap5 deficient bone marrow into a wild-type environment.
Although the phenotype of the Gimap5 knockout mouse is comparable to that of the DR. lyp/lyp rat, it remains to be clarified if the other Gimap genes are affected as demonstrated in the present study. As many of these proteins have been implicated in cell survival [7, 12, 30] , it cannot be excluded that the concomitant reduction in several of the Gimap genes outside the lyp critical interval may contribute to the severe lymphopenia observed in the periphery [4, 14, 22] .
In conclusion, a frameshift mutation in Gimap5 results in lymphopenia and precludes onset of spontaneous T1D in the diabetes prone BB rat. Reduced expression of all seven 
